ABSTRACT
Breast cancer is the most common cancer in women and is one of the three most common malignancies worldwide. Serum microRNAs (miRNAs/miRs) are ideal biomarkers for tumor diagnosis and prognosis due to their specific biological characteristics. In several different types of cancer, miRNAs are associated with cell migration and invasion. In the present study, miR253p expression levels were detected in tissue and serum samples derived from patients with breast cancer, and the diagnostic and prognostic value of miR253p in breast cancer was evaluated. Cellular function assays were performed to evaluate the role of miR253p in breast cancer. Moreover, dualluciferase reporter assays and western blotting were performed to investigate the target of miR253p. miR253p expression was upregulated in breast cancer tissue and serum samples compared with normal breast tissue and serum samples. Patients with breast cancer with high serum miR253p levels were more likely to have lymph node metastasis compared with those with low serum miR253p levels. The area under the curve for miR253p in the diagnosis of breast cancer was 0.748, with 57.1% sensitivity and 95.0% specificity. Moreover, the KaplanMeier survival curves demonstrated that patients with breast cancer with a low expression of serum miR253p had a higher overall survival rate compared with patients with a high serum miR253p expression. miR253p knockdown suppressed breast cancer cell proliferation and invasion, and transducer of ERBB2, 1 (TOB1) was identified as a potential target gene regulated by miR253p. Therefore, the present study suggested that miR253p regulated cellular functions via TOB1 in breast cancer; therefore, miR253p may serve as a breast cancer biomarker.
Subject(s)
Biomarkers, Tumor/genetics , Breast Neoplasms/genetics , Intracellular Signaling Peptides and Proteins/genetics , MicroRNAs/genetics , Tumor Suppressor Proteins/genetics , Adult , Aged , Biomarkers, Tumor/blood , Biomarkers, Tumor/metabolism , Breast Neoplasms/metabolism , Breast Neoplasms/pathology , Female , Gene Expression Regulation, Neoplastic , Humans , Intracellular Signaling Peptides and Proteins/metabolism , Lymphatic Metastasis , MCF-7 Cells , MicroRNAs/blood , MicroRNAs/metabolism , Middle Aged , Tumor Suppressor Proteins/metabolism , Up-RegulationABSTRACT
Monoamine deficit and mitochondrial dysfunction may underlie depression. Serotoninergic neurons from raphe nuclei project widely and may be involved in depression. This study used chronic unpredictable stress (CUS) in rats as a model of depression to assess the effects of CUS, exercise and fluoxetine on mitochondrial function and serotonin levels in the raphe nuclei. Rats were divided into 4 groups (6 per group): control (C); depression (D), CUS for 28days; depression+exercise (DE), treadmill exercises from days 11-28 of CUS; depression+fluoxetine (DF), fluoxetine (5mg/kg/d i.g.) from days 11 to 28 of CUS. Behavioral changes were assessed using body weight, sucrose consumption tests (anhedonia) and open field tests (locomotor/exploratory behavior). Raphe nucleus mitochondrial function was determined using the respiratory control ratio, ATP synthesis rate, and activities of superoxide dismutase and glutathione peroxidase. Serotonin levels were measured in the raphe nuclei and hippocampus. On day 28 of CUS, body weight was higher in group C than in groups D, DE and DF (P<0.001), and higher in group DE than in group D or DF (P<0.05). Sucrose consumption was higher in group C than in groups D, DE and DF (P<0.001), higher in group DE than in groups D (P<0.001) or DF (P<0.05), and higher in group DF than in group D (P<0.05). All measures of mitochondrial function were increased in group D compared with the other groups (P<0.01). Hippocampal serotonin was lower in group D than in the other groups (P<0.01); levels in the raphe nuclei were elevated in group DE compared with the remaining groups (P<0.001). CUS in rats may cause overactivation of the mitochondria in the raphe nuclei, and exercise training may suppress these changes.